Independent analyst Kunal Bothra has a buy call on Lupin Ltd. with a target price of Rs 834. The current market price of Lupin Ltd. is Rs 810.8 Time period given by the analyst is Intra Day when Lupin Ltd. price can reach the defined target. Kunal Bothra recommended to keep stoploss at Rs 795.
Lupin Ltd., incorporated in 1983, is a largecap company with a market cap of Rs 36656.52 crore. Lupin Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 12236.95 Crore to Sales Value (95.95 % of Total Sales), Export Incentives which contributed Rs 348.04 Crore to Sales Value (2.72 % of Total Sales), Other Services which contributed Rs 161.13 Crore to Sales Value (1.26 % of Total Sales) and Other Operating Revenue which contributed Rs 7.03 Crore to Sales Value (0.05 % of Total Sales)for the year ending 31-Mar-2017.
For the quarter ended 31-03-2018, the company has reported a Consolidated sales of Rs 3978.49 Crore, up 2.00 % from last quarter Sales of Rs 3900.36 Crore and down -4.41 % from last year same quarter Sales of Rs 4161.88 Crore Company has reported net profit after tax of Rs -778.86 Crore in latest quarter. The companys top management includes Dr.Desh Bandhu Gupta, Dr.K U Mada, Dr.Kamal K Sharma, Dr.Vijay Kelkar, Mr.Dileep C Choksi, Mr.Jean-Luc Belingard, Mr.Nilesh Gupta, Mr.R A Shah, Mr.Ramesh Swaminathan, Mr.Richard Zahn, Mrs.Manju D Gupta, Ms.Vinita Gupta. Company has B S R & Co. LLP as its auditoRs As on 31-03-2018, the company has a total of 452,082,850 shares outstanding.